Photoactivated Nanosheets Accelerate Nucleus Access of Cisplatin for Drug‐Resistant Cancer Therapy

Fang Gao,Xue Yang,Xinping Luo,Xuling Xue,Chenggen Qian,Minjie Sun
DOI: https://doi.org/10.1002/adfm.202001546
IF: 19
2020-01-01
Advanced Functional Materials
Abstract:Non-small cell lung cancer (NSCLC) is a primary threat to human health. Cisplatin is always in first-line treatment of NSCLC; however, cisplatin resistance restricts the application in the clinic. Herein, an innovative 2D platinum delivery platform based on manganese dioxide nanosheet is presented to overcome cisplatin-resistance and enhance theranostic efficacy in NSCLC. The photo-induced hyperthermia of nanosheets can inhibit Pt drug efflux from the multidrug resistance-associated protein (MRP1) repression. Then the intracellularl-Glutathione (GSH) consumed by MnO(2)nanosheets can reduce the generation of GSH-Pt complex. Working along both lines accelerates access to the nucleus for cisplatin. Moreover, chemo-photothermal synergistic therapy of Pt nanosheets significantly enhances therapeutic efficacy in vitro and in vivo. In addition, nanosheets can exert an on-demand activable magnetic resonance imaging contrast effect to monitor Pt drug release. For the first time, a promising photoactivated 2D vector is provided to overcome cisplatin resistance in NSCLC therapy.
What problem does this paper attempt to address?